Metropolis Healthcare Dirección
Dirección controles de criterios 1/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Surendran Chemmenkotil
Chief Executive Officer (CEO)
₹52.3m
Compensación total
| Porcentaje del salario del CEO | 23.9% |
| Permanencia del CEO | 1.3yrs |
| Participación del CEO | n/a |
| Permanencia media de la dirección | 1.3yrs |
| Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Why Investors Shouldn't Be Surprised By Metropolis Healthcare Limited's (NSE:METROPOLIS) P/E
Mar 28
Capital Allocation Trends At Metropolis Healthcare (NSE:METROPOLIS) Aren't Ideal
Jan 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Share Price Matching Investor Opinion
Dec 23Does Metropolis Healthcare (NSE:METROPOLIS) Have A Healthy Balance Sheet?
Sep 08Metropolis Healthcare (NSE:METROPOLIS) Could Be Struggling To Allocate Capital
Jun 20Metropolis Healthcare (NSE:METROPOLIS) Might Be Having Difficulty Using Its Capital Effectively
Mar 14Metropolis Healthcare's (NSE:METROPOLIS) Dividend Will Be ₹8.00
Feb 13Metropolis Healthcare Limited's (NSE:METROPOLIS) Intrinsic Value Is Potentially 25% Below Its Share Price
Sep 25Is Metropolis Healthcare (NSE:METROPOLIS) A Risky Investment?
Sep 10Metropolis Healthcare (NSE:METROPOLIS) Has A Rock Solid Balance Sheet
Jun 07Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
May 16Is Now The Time To Put Metropolis Healthcare (NSE:METROPOLIS) On Your Watchlist?
Mar 17Capital Investments At Metropolis Healthcare (NSE:METROPOLIS) Point To A Promising Future
Jan 29Do Metropolis Healthcare's (NSE:METROPOLIS) Earnings Warrant Your Attention?
Dec 14Metropolis Healthcare (NSE:METROPOLIS) Looks To Prolong Its Impressive Returns
Oct 12Should You Be Adding Metropolis Healthcare (NSE:METROPOLIS) To Your Watchlist Today?
Aug 27Here's What Metropolis Healthcare's (NSE:METROPOLIS) Strong Returns On Capital Mean
Jul 06I Ran A Stock Scan For Earnings Growth And Metropolis Healthcare (NSE:METROPOLIS) Passed With Ease
May 28Metropolis Healthcare (NSE:METROPOLIS) Is Aiming To Keep Up Its Impressive Returns
Mar 29Does Metropolis Healthcare's (NSE:METROPOLIS) Share Price Gain of 15% Match Its Business Performance?
Mar 11Trade Alert: The Chief Executive Officer Of Metropolis Healthcare Limited (NSE:METROPOLIS), Vijender Singh, Has Sold Some Shares Recently
Feb 24Metropolis Healthcare Limited (NSE:METROPOLIS) Passed Our Checks, And It's About To Pay A ₹8.00 Dividend
Feb 12Metropolis Healthcare Limited's (NSE:METROPOLIS) 0.4% Dividend Yield Looks Pretty Interesting
Feb 09
Is Metropolis Healthcare Limited (NSE:METROPOLIS) Popular Amongst Insiders?
Jan 25Is Metropolis Healthcare Limited's (NSE:METROPOLIS) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Jan 10Metropolis Healthcare (NSE:METROPOLIS) Knows How to Allocate Capital
Dec 26The Metropolis Healthcare (NSE:METROPOLIS) Share Price Is Up 54% And Shareholders Are Holding On
Dec 11Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹1b |
| Sep 30 2023 | n/a | n/a | ₹1b |
| Jun 30 2023 | n/a | n/a | ₹1b |
| Mar 31 2023 | ₹52m | ₹13m | ₹1b |
Compensación vs. Mercado: La compensación total de Surendran($USD627.98K) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD381.60K).
Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Surendran con los resultados de la empresa.
CEO
Surendran Chemmenkotil
1.3yrs
Permanencia
₹52,318,552
Compensación
Mr. Surendran Chemmenkotil is Chief Executive Officer of Metropolis Healthcare Limited from January 2, 2023. He is a seasoned leader with rich and diverse experience across consumer facing companies such a...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Executive Chairman | 18.7yrs | ₹18.00m | 18.68% ₹ 17.3b | |
| Chief Executive Officer | 1.3yrs | ₹52.32m | sin datos | |
| Chief Financial Officer | 4.4yrs | ₹13.83m | sin datos | |
| MD & Executive Director | 1.3yrs | ₹52.40m | 0.35% ₹ 328.2m | |
| Group President and Chief of Science & Innovation | no data | sin datos | sin datos | |
| Chief Operating Officer – Operations | no data | sin datos | sin datos | |
| Chief Scientific Officer & Group CSR Head | no data | sin datos | sin datos | |
| Company Secretary & Compliance Officer | less than a year | sin datos | sin datos | |
| Head of Public Relations & Corporate Communications | 2.6yrs | sin datos | sin datos | |
| Chief Marketing Officer | less than a year | sin datos | sin datos | |
| Chief People Officer | 4.3yrs | sin datos | sin datos | |
| Managing Director of RV Metropolis | no data | sin datos | sin datos |
1.3yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de METROPOLIS no se considera experimentado ( 1.3 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Founder & Executive Chairman | 18.7yrs | ₹18.00m | 18.68% ₹ 17.3b | |
| MD & Executive Director | 15.9yrs | ₹52.40m | 0.35% ₹ 328.2m | |
| Non-Executive Independent Director | 3.9yrs | ₹1.15m | sin datos | |
| Non-Executive Independent Director | 5.6yrs | ₹765.00k | sin datos | |
| Non-Executive Independent Director | 5.6yrs | ₹1.19m | 0.00028% ₹ 258.9k | |
| Non-Executive Non-Independent Director | 2.9yrs | sin datos | sin datos |
5.6yrs
Permanencia media
58yo
Promedio de edad
Junta con experiencia: La junta directiva de METROPOLIS se considera experimentada (5.6 años de antigüedad promedio).